Literature DB >> 10427

Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors.

H H Harms.   

Abstract

pA2 values against isoproterenol were determined for a number of cardioselective and noncardioselective beta adrenergic receptor blocking agents using human and guinea-pig isolated atrial and bronchial or tracheal preparations to study possible species differences. No significant differences in pA2 values for propranolol, pindolol, Ro 3-4787, acebutolol, atenolol, practolol, metoprolol, H 87/07 and tolamolol on bronchial or tracheal beta adrenergic receptors of both species were found. With respect to atrial beta adrenergic receptors, significantly lower pA2 values for human preparations, as compared to guinea-pig preparations, were found for tolamolol and CI 775. These are the only two agents in the series that derive their cardioselectivities from specific nitrogen substitutents. The different potencies of only these two compounds in antagonizing isoproterenol on atrial beta adrenergic receptors of both species suggest a difference in an accessory receptor area close to the site that interacts with the nitrogen atom of beta adrenergic agents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10427

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

2.  Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes.

Authors:  R A Bond; D E Clarke
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

3.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

4.  Adrenoceptor-mediated changes of action potential and force of contraction in human isolated ventricular heart muscle.

Authors:  H Jakob; H Nawrath; J Rupp
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

5.  Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?

Authors:  K L Williamson; K J Broadley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney.

Authors:  P P Lakhlani; F Amenta; P Napoleone; L Felici; D C Eikenburg
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Reduced brain serotonergic activity after repeated treatment with beta-adrenoceptor antagonists.

Authors:  H Hallberg; O Almgren; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Authors:  J D Fitzgerald; R Ruffin; K G Smedstad; R Roberts; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

9.  Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro.

Authors:  P R Butchers; I F Skidmore; C J Vardey; A Wheeldon
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

10.  Classification of beta-adrenoceptors in human isolated bronchus.

Authors:  R G Goldie; J W Paterson; D Spina; J L Wale
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.